A-dmDT390-bisFv(UCHT1) fusion protein

· Angimmune LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for A-dmDT390-bisFv(UCHT1) fusion protein, covering 2016-10-25 to 2016-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma [Phase 1, Phase 2]

See pricing